Trials / Conditions / Bone Marrow Failure Syndromes

Bone Marrow Failure Syndromes

15 registered clinical trials studyying Bone Marrow Failure Syndromes — 4 currently recruiting.

Status	Trial	Sponsor	Phase
Suspended	Methadone as an Alternative Treatment for Children Underdoing HSCT NCT06940570	University of Texas Southwestern Medical Center	Phase 3
Completed	UCB Transplant for Hematological Diseases Using a Non Myeloablative Prep NCT02722668	Masonic Cancer Center, University of Minnesota	Phase 2
Recruiting	Reduced Intensity Conditioning and Familial HLA-Mismatched BMT for Non-Malignant Disorders NCT03128996	Washington University School of Medicine	Phase 1 / Phase 2
Recruiting	Investigation of the Genetics of Hematologic Diseases NCT02720679	St. Jude Children's Research Hospital	—
Recruiting	Fludarabine Based RIC for Bone Marrow Failure Syndromes NCT02928991	Children's Hospital of Philadelphia	EARLY_Phase 1
Completed	Treosulfan-based Versus Busulfan-based Conditioning in Paediatric Patients With Non-malignant Diseases NCT02349906	medac GmbH	Phase 2
Completed	Transplantation of Partially Mismatched Related or Matched Unrelated Bone Marrow for Patients With Refractory NCT02224872	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins	Phase 2
Completed	Memory T-cell Infusion to Improve Immunity After TCR-alpha/Beta Depleted Hematopoietic Stem Cell Transplantati NCT02337595	Federal Research Institute of Pediatric Hematology, Oncology and Immunology	Phase 1 / Phase 2
Completed	Nandrolone Decanoate in the Treatment of Telomeropathies NCT02055456	University of Sao Paulo	Phase 1 / Phase 2
Recruiting	Expanded Access Protocol Using CD3+/CD19+ Depleted PBSC NCT02356653	Children's Hospital of Philadelphia	EARLY_Phase 1
Completed	Reduced Intensity Conditioning Using CD3+/CD19+ Depletion for Non Malignant Transplantable Diseases NCT02277639	Children's Hospital of Philadelphia	Phase 2
Withdrawn	Phase I/II Pilot Study of Mixed Chimerism to Treat Hemoglobinopathies NCT01419704	Talaris Therapeutics Inc.	Phase 1 / Phase 2
Unknown	Identifying Characteristics of Bone Marrow Failure Syndromes NCT00315419	Office of Rare Diseases (ORD)	—
Completed	Comparison of Cy-Atg Vs Cy-Flu-Atg for the Conditioning Therapy in Allo-HCT NCT00774527	Cooperative Study Group A for Hematology	Phase 3
Terminated	Unrelated Donor Transplant for Malignant and Non-Malignant Disorders NCT01050439	Columbia University	Phase 2